GLP3-ELO (Eloralintide) is an investigational long-acting amylin receptor agonist studied in metabolic, appetite-regulation, and body-composition research. Current research is evaluating its effects on satiety signaling, energy balance, and weight-related metabolic pathways.
For research use only. Not for human or veterinary use.
Reviews
There are no reviews yet.